Literature DB >> 36215486

Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B/Victoria and B/Yamagata lineages.

Miruna E Rosu1, Pascal Lexmond1, Theo M Bestebroer1, Blake M Hauser2, Derek J Smith2, Sander Herfst1, Ron A M Fouchier1.   

Abstract

Influenza B virus primarily infects humans, causing seasonal epidemics globally. Two antigenic variants-Victoria-like and Yamagata-like-were detected in the 1980s, of which the molecular basis of emergence is still incompletely understood. Here, the antigenic properties of a unique collection of historical virus isolates, sampled from 1962 to 2000 and passaged exclusively in mammalian cells to preserve antigenic properties, were determined with the hemagglutination inhibition assay and an antigenic map was built to quantify and visualize the divergence of the lineages. The antigenic map revealed only three distinct antigenic clusters-Early, Victoria, and Yamagata-with relatively little antigenic diversity in each cluster until 2000. Viruses with Victoria-like antigenic properties emerged around 1972 and diversified subsequently into two genetic lineages. Viruses with Yamagata-like antigenic properties evolved from one lineage and became clearly antigenically distinct from the Victoria-like viruses around 1988. Recombinant mutant viruses were tested to show that insertions and deletions (indels), as observed frequently in influenza B virus hemagglutinin, had little effect on antigenic properties. In contrast, amino-acid substitutions at positions 148, 149, 150, and 203, adjacent to the hemagglutinin receptor binding site, determined the main antigenic differences between the Early, Victoria-like, and Yamagata-like viruses. Surprisingly, substitutions at two of the four positions reverted in recent viruses of the Victoria lineage, resulting in antigenic properties similar to viruses circulating ∼50 y earlier. These data shed light on the antigenic diversification of influenza viruses and suggest there may be limits to the antigenic evolution of influenza B virus.

Entities:  

Keywords:  antigenic evolution; hemagglutinin; influenza B virus; vaccines

Mesh:

Substances:

Year:  2022        PMID: 36215486      PMCID: PMC9586307          DOI: 10.1073/pnas.2211616119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  45 in total

1.  The receptor-destroying enzyme of V. cholerae.

Authors:  F M BURNET; J D STONE
Journal:  Aust J Exp Biol Med Sci       Date:  1947-09

2.  Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.

Authors:  Angeliki Melidou; Olav Hungnes; Dmitriy Pereyaslov; Cornelia Adlhoch; Hannah Segaloff; Emmanuel Robesyn; Pasi Penttinen; Sonja J Olsen
Journal:  Vaccine       Date:  2020-07-03       Impact factor: 3.641

3.  Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B/Victoria and B/Yamagata lineages.

Authors:  Miruna E Rosu; Pascal Lexmond; Theo M Bestebroer; Blake M Hauser; Derek J Smith; Sander Herfst; Ron A M Fouchier
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

4.  Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus.

Authors:  P A Rota; M L Hemphill; T Whistler; H L Regnery; A P Kendal
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

5.  The antigenic structure of the influenza B virus hemagglutinin: operational and topological mapping with monoclonal antibodies.

Authors:  M T Berton; R G Webster
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

6.  Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains.

Authors:  M Krystal; J F Young; P Palese; I A Wilson; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

7.  Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.

Authors:  Weina Sun; Davina S Kang; Allen Zheng; Sean T H Liu; Felix Broecker; Viviana Simon; Florian Krammer; Peter Palese
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

Review 8.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

9.  Integrating influenza antigenic dynamics with molecular evolution.

Authors:  Trevor Bedford; Marc A Suchard; Philippe Lemey; Gytis Dudas; Victoria Gregory; Alan J Hay; John W McCauley; Colin A Russell; Derek J Smith; Andrew Rambaut
Journal:  Elife       Date:  2014-02-04       Impact factor: 8.140

10.  An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines.

Authors:  Jenna J Guthmiller; Henry A Utset; Carole Henry; Lei Li; Nai-Ying Zheng; Weina Sun; Marcos Costa Vieira; Seth Zost; Min Huang; Scott E Hensley; Sarah Cobey; Peter Palese; Patrick C Wilson
Journal:  mBio       Date:  2021-06-15       Impact factor: 7.867

View more
  1 in total

1.  Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B/Victoria and B/Yamagata lineages.

Authors:  Miruna E Rosu; Pascal Lexmond; Theo M Bestebroer; Blake M Hauser; Derek J Smith; Sander Herfst; Ron A M Fouchier
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.